TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 27221567

Group type: EXPERIMENTAL
Intervention: PM2.5 (150 μg/m(3))
Number of subjects: 0

Group type: COMPARATOR
Intervention: Filtered Air (FA)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Ozone (240 μg/m(3))
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: PM2.5 plus Ozone
Number of subjects: 0
Study: 24366937

Group type: EXPERIMENTAL
Intervention: Erlotinib 150 mg orally daily for 2 years
Number of subjects: 835

Group type: COMPARATOR
Intervention: Observation
Number of subjects: 835

Group type: EXPERIMENTAL
Intervention: Erlotinib with positive FISH EGFR score
Number of subjects: 835
Study: 22826980

Group type: EXPERIMENTAL
Intervention: Intensive insulin therapy
Number of subjects: 81
Study: 20565202

Group type: EXPERIMENTAL
Intervention: Group voice in decision-making procedures (equal opportunities for interest groups to express opinions)
Number of subjects: 0

Group type: COMPARATOR
Intervention: No voice procedures (unilateral decision-making)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Unequal group-voice procedures (one interest group receives voice, another does not)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Individual's own level of knowledge about CCS
Number of subjects: 0
Study: 19065853

Group type: EXPERIMENTAL
Intervention: Fractal patterns with a fractal dimension of 1.3
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Fractal patterns with different fractal dimensions
Number of subjects: 0
Study: 15667494

Group type: EXPERIMENTAL
Intervention: Tegaserod 2 mg b.i.d.
Number of subjects: 1264

Group type: EXPERIMENTAL
Intervention: Tegaserod 6 mg b.i.d.
Number of subjects: 1264

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1264
Study: 12839848

Group type: EXPERIMENTAL
Intervention: Preoperative chemotherapy with FLAC/granulocyte-colony-stimulating factor
Number of subjects: 53

Group type: COMPARATOR
Intervention: Postoperative chemotherapy
Number of subjects: 53
Study: 10663415

Group type: EXPERIMENTAL
Intervention: bupropion 300 mg/day
Number of subjects: 91

Group type: EXPERIMENTAL
Intervention: bupropion 150 mg/day
Number of subjects: 91

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 91
Study: 8797405

Group type: EXPERIMENTAL
Intervention: Rapid inspiration without an end‐inspiratory pause
Number of subjects: 15

Group type: COMPARATOR
Intervention: Slow inspiration with a 4‐s end‐inspiratory pause
Number of subjects: 15
Study: 1556626

Group type: EXPERIMENTAL
Intervention: Three Knowles pins
Number of subjects: 6

Group type: COMPARATOR
Intervention: Compression hip screw (CHS) and side plate
Number of subjects: 6
Study: 4029413

Group type: EXPERIMENTAL
Intervention: Totally implanted venous access systems
Number of subjects: 42
Study: 29383896

Group type: EXPERIMENTAL
Intervention: Conventional treatment + acupuncture therapy (observation group)
Number of subjects: 79

Group type: COMPARATOR
Intervention: Conventional treatment (control group)
Number of subjects: 79
Study: 27798895

Group type: EXPERIMENTAL
Intervention: Oral tegafur/gimeracil/oteracil (S‐1)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Uracil‐tegafur/leucovorin (UFT/LV)
Number of subjects: 0
Study: 25023200

Group type: EXPERIMENTAL
Intervention: Electronic alert system for acute kidney injury
Number of subjects: 2373
Study: 22681551

Group type: EXPERIMENTAL
Intervention: Lipido‐Colloid Technology‐Nano‐OligoSaccharide Factor (TLC‐NOSF) dressing
Number of subjects: 187

Group type: COMPARATOR
Intervention: TLC dressing (control group)
Number of subjects: 187
Study: 20658835

Group type: EXPERIMENTAL
Intervention: Emotionally expressive writing (EMO; n = 31)
Number of subjects: 62

Group type: COMPARATOR
Intervention: Control group writing about facts of diagnosis and treatment (CTL; n = 31)
Number of subjects: 62
Study: 18209982

Group type: EXPERIMENTAL
Intervention: Minimally invasive thymectomy (including robotic-assisted surgery)
Number of subjects: 0
Study: 16022024

Group type: EXPERIMENTAL
Intervention: Hydrabrush
Number of subjects: 110

Group type: COMPARATOR
Intervention: Sonicare
Number of subjects: 110

Group type: COMPARATOR
Intervention: Oral-B
Number of subjects: 110
Study: 11805503

Group type: EXPERIMENTAL
Intervention: BioMask treatment with excimer laser phototherapeutic keratectomy (PTK)
Number of subjects: 22
Study: 9916956

Group type: EXPERIMENTAL
Intervention: Depot leuprolide (3.75 mg/mo)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study: 7583865

Group type: EXPERIMENTAL
Intervention: Perfume inhalation from magazine scent strips
Number of subjects: 29

Group type: COMPARATOR
Intervention: Normal saline (placebo)
Number of subjects: 29
Study: 2305013

Group type: EXPERIMENTAL
Intervention: Scopolamine 0.22 mg/70 kg
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Scopolamine 0.43 mg/70 kg
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Scopolamine 0.65 mg/70 kg
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study: 348535

Group type: EXPERIMENTAL
Intervention: Mianserin (10 mg t.d.s. for the first week, increasing to 20 mg t.d.s. for the subsequent three weeks)
Number of subjects: 106

Group type: COMPARATOR
Intervention: Amitriptyline (25 mg t.d.s. for the first week, increasing to 50 mg t.d.s. for the subsequent three weeks)
Number of subjects: 106
Study: 30167733

Group type: EXPERIMENTAL
Intervention: Voucher group
Number of subjects: 4248

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 4248

Group type: EXPERIMENTAL
Intervention: Neighborhood % poverty
Number of subjects: 4248

Group type: EXPERIMENTAL
Intervention: Housing discrimination
Number of subjects: 4248
Study: 28291862

Group type: EXPERIMENTAL
Intervention: Splinted prostheses with short implants (short group SP)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Nonsplinted prostheses with regular implants (regular group NSP)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Splinted prostheses with regular implants (regular group SP)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Nonsplinted prostheses with short implants (short group NSP)
Number of subjects: 12
Study: 25761644

Group type: EXPERIMENTAL
Intervention: iPod touch device for stigma reduction intervention
Number of subjects: 0
Study: 23164373

Group type: EXPERIMENTAL
Intervention: Chlorhexidine-alcohol
Number of subjects: 100

Group type: COMPARATOR
Intervention: Povidone-iodine
Number of subjects: 100
Study: 20497432

Group type: COMPARATOR
Intervention: Oral prednisolone (group I)
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Peribulbar triamcinolone orbital injection (group II)
Number of subjects: 29
Study: 19047532

Group type: EXPERIMENTAL
Intervention: Intensive lifestyle intervention
Number of subjects: 5145

Group type: COMPARATOR
Intervention: Diabetes support and education (control)
Number of subjects: 5145

Group type: EXPERIMENTAL
Intervention: Both interventions (intensive lifestyle intervention and diabetes support and education)
Number of subjects: 5145
Study: 16324269

Group type: EXPERIMENTAL
Intervention: Capsaicin inhalation cough challenge test by dosimeter method
Number of subjects: 91
Study: 12826636

Group type: EXPERIMENTAL
Intervention: 40 mg of oral prednisone once daily for 10 days
Number of subjects: 147

Group type: COMPARATOR
Intervention: Placebo for 10 days
Number of subjects: 147
Study: 10987447

Group type: EXPERIMENTAL
Intervention: Hierarchy message counseling promoting male and female condoms, diaphragm, cervical cap, spermicides, and withdrawal.
Number of subjects: 3

Group type: COMPARATOR
Intervention: Counseling about condoms only (control group).
Number of subjects: 3
Study: 8651227

Group type: EXPERIMENTAL
Intervention: multiple vitamin/mineral supplement
Number of subjects: 3318

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 3318
Study: 2052468

Group type: EXPERIMENTAL
Intervention: Volmax 8 mg orally every 12 hours for 3 days
Number of subjects: 23

Group type: COMPARATOR
Intervention: Proventil Repetabs 8 mg orally every 12 hours for 3 days
Number of subjects: 23
Study: 6861447

Group type: EXPERIMENTAL
Intervention: Fasted group (group 1)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Fed group (group 2)
Number of subjects: 10
Study: 28903576

Group type: EXPERIMENTAL
Intervention: Experimental group (D1)
Number of subjects: 255

Group type: EXPERIMENTAL
Intervention: Experimental group (D2)
Number of subjects: 255

Group type: COMPARATOR
Intervention: Standard of Care (SOC)
Number of subjects: 255

Group type: EXPERIMENTAL
Intervention: Experimental group
Number of subjects: 255

Group type: COMPARATOR
Intervention: All groups
Number of subjects: 255

Group type: EXPERIMENTAL
Intervention: Overall
Number of subjects: 255
Study: 28091350

Group type: EXPERIMENTAL
Intervention: High-flavanone (HF; 70.5 mg) drink
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control drink (zero-flavanone)
Number of subjects: 40
Study: 23713782

Group type: EXPERIMENTAL
Intervention: KOH 5% solution
Number of subjects: 29

Group type: COMPARATOR
Intervention: KOH 2.5% solution
Number of subjects: 29
Study: 23801093

Group type: EXPERIMENTAL
Intervention: Commercial immuno-enhancing supplement 5 days preoperatively
Number of subjects: 95

Group type: COMPARATOR
Intervention: No supplements (Control)
Number of subjects: 95
Study: 21602565

Group type: EXPERIMENTAL
Intervention: Platelet-rich plasma injection
Number of subjects: 54

Group type: COMPARATOR
Intervention: Saline (placebo) injection
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Ultrasonographic examination
Number of subjects: 54
Study: 18356109

Group type: EXPERIMENTAL
Intervention: 41.6 Gy in 13 fractions of 3.2 Gy
Number of subjects: 2236

Group type: EXPERIMENTAL
Intervention: 39 Gy in 13 fractions of 3.0 Gy
Number of subjects: 2236

Group type: COMPARATOR
Intervention: 50 Gy in 25 fractions of 2.0 Gy
Number of subjects: 2236
Study: 17055945

Group type: EXPERIMENTAL
Intervention: Magnesium sulphate
Number of subjects: 256

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 256
Study: 14998080

Group type: EXPERIMENTAL
Intervention: Intravenous moxifloxacin 400 mg once-daily
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Oral moxifloxacin 400 mg once-daily
Number of subjects: 49
Study: 11192323

Group type: COMPARATOR
Intervention: TNF2 allele presence in primary sclerosing cholangitis patients (A at position -308)
Number of subjects: 139

Group type: COMPARATOR
Intervention: TNF2 allele presence in auto-immune hepatitis patients
Number of subjects: 139

Group type: COMPARATOR
Intervention: IL-10 and TGFbeta1 polymorphisms
Number of subjects: 139

Group type: COMPARATOR
Intervention: Genotype association with Child's class in primary biliary cirrhosis
Number of subjects: 139
Study: 8791185

Group type: EXPERIMENTAL
Intervention: Fluoxetine treatment
Number of subjects: 43

Group type: COMPARATOR
Intervention: Placebo therapy
Number of subjects: 43
Study: 1325167

Group type: EXPERIMENTAL
Intervention: Timetabled visiting by Health Visitor Assistants (HVAs)
Number of subjects: 0

Group type: COMPARATOR
Intervention: No timetabled visiting (Control group)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Timetabled visiting by HVAs
Number of subjects: 0
Study: 6712539

Group type: EXPERIMENTAL
Intervention: Low-fat diet with a high ratio of polyunsaturated-to-saturated fatty acids
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Return to original diet
Number of subjects: 38
Study: 30968210

Group type: EXPERIMENTAL
Intervention: RCTs with adequate allocation concealment (43 out of 261, 16.47%)
Number of subjects: 6997

Group type: EXPERIMENTAL
Intervention: Jadad Quality Scale evaluation
Number of subjects: 6997
Study: 29907335

Group type: EXPERIMENTAL
Intervention: Mindfulness-based intervention (weekly sessions for 8 weeks)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Physiotherapy exercise program (8-week program)
Number of subjects: 120
Study: 26951389

Group type: EXPERIMENTAL
Intervention: Cycle-exercise group (EX)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Sedentary control group (CON)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Physical activity levels (Long-Term Phase)
Number of subjects: 30
Study: 24983262

Group type: EXPERIMENTAL
Intervention: Djembe drumming sessions (40 minutes)
Number of subjects: 2
Study: 22876442

Group type: EXPERIMENTAL
Intervention: Modified Linggui Zhugan decoction combined with short-term very low calorie diets (VLCDs)
Number of subjects: 85

Group type: COMPARATOR
Intervention: Basic weight-reduction treatment (Control group)
Number of subjects: 85
Study: 20213672

Group type: EXPERIMENTAL
Intervention: TETRA handset
Number of subjects: 53

Group type: COMPARATOR
Intervention: Sham control signals
Number of subjects: 53
Study: 18032149

Group type: EXPERIMENTAL
Intervention: Upper limb dexterity training
Number of subjects: 15

Group type: COMPARATOR
Intervention: Lower limb training
Number of subjects: 15
Study: 15860240

Group type: EXPERIMENTAL
Intervention: Diabetes passport intervention
Number of subjects: 150

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 150
Study: 12537209

Group type: EXPERIMENTAL
Intervention: Modified Fontan operation
Number of subjects: 40
Study: 10793433

Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy (CBT), n = 25
Number of subjects: 49

Group type: COMPARATOR
Intervention: No Therapy (NT), n = 24
Number of subjects: 49
Study: 8656502

Group type: EXPERIMENTAL
Intervention: Lamivudine 150 mg every 12 hours plus zidovudine
Number of subjects: 223

Group type: EXPERIMENTAL
Intervention: Lamivudine 300 mg every 12 hours plus zidovudine
Number of subjects: 223

Group type: COMPARATOR
Intervention: Zidovudine monotherapy
Number of subjects: 223
Study: 1658975

Group type: EXPERIMENTAL
Intervention: Lisinopril 10 mg once daily
Number of subjects: 367

Group type: EXPERIMENTAL
Intervention: Lisinopril 20 mg once daily
Number of subjects: 367

Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 367
Study: 6628006

Group type: EXPERIMENTAL
Intervention: High-frequency jet ventilation (HFJV)
Number of subjects: 309

Group type: COMPARATOR
Intervention: Volume‐cycled ventilator (VCV)
Number of subjects: 309
Study: 29112048

Group type: EXPERIMENTAL
Intervention: Low-residue diet (LRD)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Clear liquid diet (CLD)
Number of subjects: 0
Study: 28994359

Group type: EXPERIMENTAL
Intervention: Eating ≥5 servings of fruits and vegetables (F&V) per day
Number of subjects: 279

Group type: EXPERIMENTAL
Intervention: Concern about wasting food when serving F&V
Number of subjects: 279

Group type: EXPERIMENTAL
Intervention: Driving one's own car to the store
Number of subjects: 279
Study: 26329397

Group type: EXPERIMENTAL
Intervention: Denosumab
Number of subjects: 5543

Group type: EXPERIMENTAL
Intervention: Zoledronic acid
Number of subjects: 5543

Group type: COMPARATOR
Intervention: Skeletal-related events (SREs)
Number of subjects: 5543
Study: 23945841

Group type: EXPERIMENTAL
Intervention: Interactive web-based training module
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group (no training)
Number of subjects: 40
Study: 22569730

Group type: EXPERIMENTAL
Intervention: Educational intervention consisting of 15 preconception health education sessions
Number of subjects: 77

Group type: COMPARATOR
Intervention: Non-intervention group
Number of subjects: 77

Group type: EXPERIMENTAL
Intervention: Educational intervention
Number of subjects: 77
Study: 21284250

Group type: EXPERIMENTAL
Intervention: Pro‐Argin formula whitening dentifrice (test group)
Number of subjects: 92

Group type: COMPARATOR
Intervention: Original Pro‐Argin formula dentifrice (control group)
Number of subjects: 92
Study: 17377691

Group type: EXPERIMENTAL
Intervention: 0.3% Triclosan varnish applied twice a year (every half year) for one year.
Number of subjects: 606

Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned).
Number of subjects: 606
Study: 15704508

Group type: EXPERIMENTAL
Intervention: 12 additional therapy sessions (over four weeks) comprising exercises aimed at improving lateral weight transference in sitting delivered by trained physiotherapy assistants
Number of subjects: 35

Group type: COMPARATOR
Intervention: Usual care including physiotherapy
Number of subjects: 35
Study: 11897208

Group type: EXPERIMENTAL
Intervention: niacin/lovastatin 500/10 mg
Number of subjects: 814

Group type: EXPERIMENTAL
Intervention: niacin/lovastatin 1,000/20 mg
Number of subjects: 814

Group type: EXPERIMENTAL
Intervention: niacin/lovastatin 1,500/30 mg
Number of subjects: 814

Group type: EXPERIMENTAL
Intervention: niacin/lovastatin 2,000/40 mg
Number of subjects: 814
Study: 9854276

Group type: EXPERIMENTAL
Intervention: Guided imagery therapy for 6 weeks
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Guided imagery therapy
Number of subjects: 50

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 50
Study: 8548055

Group type: EXPERIMENTAL
Intervention: High-dose progesterone (0.714 mg.kg‐1.h‐1 for 60 min followed by 0.45 mg.kg‐1.h‐1 over 315 min)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Vehicle (control)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: High-dose progesterone
Number of subjects: 8
Study: 2122514

Group type: EXPERIMENTAL
Intervention: Streptokinase (SK)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Recombinant tissue‐type plasminogen activator (rtPA)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Comparison of rtPA and SK
Number of subjects: 30
Study: 417615

Group type: EXPERIMENTAL
Intervention: Behavioral therapy
Number of subjects: 120

Group type: COMPARATOR
Intervention: Mazindol
Number of subjects: 120

Group type: COMPARATOR
Intervention: Diethylpropion
Number of subjects: 120

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 120
Study: 30721997

Group type: EXPERIMENTAL
Intervention: Recombinant human lactoferrin
Number of subjects: 54

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 54
Study: 28118454

Group type: EXPERIMENTAL
Intervention: Continuous glucose monitoring
Number of subjects: 161

Group type: COMPARATOR
Intervention: Conventional treatment
Number of subjects: 161

Group type: COMPARATOR
Intervention: Conventional treatment during washout
Number of subjects: 161
Study: 26414234

Group type: EXPERIMENTAL
Intervention: Cranial electrotherapy stimulation (CES) at 2 mA for 20 minutes, five days a week for 2 weeks
Number of subjects: 16

Group type: COMPARATOR
Intervention: Sham treatment (CES device turned on and off)
Number of subjects: 16
Study: 23472927

Group type: EXPERIMENTAL
Intervention: Single-dose intravenous cephalothin
Number of subjects: 102

Group type: COMPARATOR
Intervention: Single-dose intravenous cephalothin plus oral amoxicillin/clavulanate for 7 days
Number of subjects: 102
Study: 21193063

Group type: EXPERIMENTAL
Intervention: Atrial overdrive pacing (AP) with left ventricular (LV) pacing
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Atrial overdrive pacing (AP) with biventricular (BiV) pacing
Number of subjects: 28

Group type: COMPARATOR
Intervention: Atrial sensing (AS) with left ventricular (LV) pacing
Number of subjects: 28

Group type: COMPARATOR
Intervention: Atrial sensing (AS) with biventricular (BiV) pacing
Number of subjects: 28
Study: 19183157

Group type: EXPERIMENTAL
Intervention: Dexlansoprazole MR 60 mg
Number of subjects: 4092

Group type: EXPERIMENTAL
Intervention: Dexlansoprazole MR 90 mg
Number of subjects: 4092

Group type: COMPARATOR
Intervention: Lansoprazole 30 mg
Number of subjects: 4092

Group type: EXPERIMENTAL
Intervention: All treatments
Number of subjects: 4092

Group type: EXPERIMENTAL
Intervention: Dexlansoprazole MR 90 mg in moderate-to-severe EO
Number of subjects: 4092
Study: 17062036

Group type: EXPERIMENTAL
Intervention: Broad-band ultraviolet B (BB-UVB) phototherapy
Number of subjects: 32
Study: 15016561

Group type: EXPERIMENTAL
Intervention: Bimatoprost 0.03% QD
Number of subjects: 379

Group type: COMPARATOR
Intervention: Timolol 0.5% BID
Number of subjects: 379

Group type: EXPERIMENTAL
Intervention: Bimatoprost 0.03% BID
Number of subjects: 379
Study: 11843388

Group type: EXPERIMENTAL
Intervention: Vaginal misoprostol (50 microg)
Number of subjects: 370

Group type: COMPARATOR
Intervention: Vaginal dinoprostone
Number of subjects: 370
Study: 9542607

Group type: EXPERIMENTAL
Intervention: Immunotherapy with birch-pollen extract
Number of subjects: 4

Group type: COMPARATOR
Intervention: Placebo administration
Number of subjects: 4
Study: 7929825

Group type: EXPERIMENTAL
Intervention: Exhaustive exercise under normoxic conditions
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Exhaustive exercise under hypoxic conditions
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Exhaustive exercise
Number of subjects: 6
Study: 3349417

Group type: EXPERIMENTAL
Intervention: Protein A treatment (Prosorba column containing 50 or 200 mg protein A, administered 12 times either once per week or three times per week)
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Protein A treatment (Prosorba column)
Number of subjects: 7
Study: 29231046

Group type: EXPERIMENTAL
Intervention: Hydrotherapy during the active phase of labor
Number of subjects: 40
Study: 28882371

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine (0.1 mg kg−1) and midazolam (1.0 mg kg−1)
Number of subjects: 9

Group type: COMPARATOR
Intervention: Alfaxalone (15 mg kg−1) and midazolam (1.0 mg kg−1)
Number of subjects: 9
Study: 26076302

Group type: EXPERIMENTAL
Intervention: Ice spray
Number of subjects: 22

Group type: COMPARATOR
Intervention: Water spray
Number of subjects: 22
Study: 23873559

Group type: EXPERIMENTAL
Intervention: Added P from KH2PO4 at levels of 0, 0.7, 1.4, or 2.1 g/kg of diet
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Added phytase at levels of 500 or 1,000 phytase units
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Diet with 5 g of highly soluble calcium (HSC)
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Diet with 1,000 units of added phytase
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Phytase-related efficiency of ileal digestible P utilization for bone mineralization
Number of subjects: 96

Group type: COMPARATOR
Intervention: KH2PO4 without added phytase
Number of subjects: 96
Study: 20946200

Group type: EXPERIMENTAL
Intervention: Group CBT
Number of subjects: 110

Group type: EXPERIMENTAL
Intervention: Individual CBT
Number of subjects: 110

Group type: COMPARATOR
Intervention: Meta-analysis of individual CBT vs group CBT
Number of subjects: 110
Study: 19688036

Group type: EXPERIMENTAL
Intervention: SODIS intervention with a mean compliance of 32.1%.
Number of subjects: 725

Group type: COMPARATOR
Intervention: Control group (no SODIS intervention).
Number of subjects: 725

Group type: EXPERIMENTAL
Intervention: SODIS intervention.
Number of subjects: 725

Group type: COMPARATOR
Intervention: Control group.
Number of subjects: 725
Study: 16820626

Group type: EXPERIMENTAL
Intervention: Mitral valve repair with CABG (repair group, n=50)
Number of subjects: 107

Group type: COMPARATOR
Intervention: CABG only (CABG group, n=57)
Number of subjects: 107

Group type: EXPERIMENTAL
Intervention: Mitral valve repair with CABG (repair group)
Number of subjects: 107

Group type: COMPARATOR
Intervention: CABG only (CABG group)
Number of subjects: 107

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 107